Open Label Safety/Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) in Patients With Cervical Dystonia

Clinical trial NCT00702754 · COMPLETED

Trial details

NCT number: NCT00702754
Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cervical Dystonia

Start date: 2001-06-01
Primary completion: 2008-05-01
Enrollment: 502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.